Real-World Data of Osimertinib in Patients with Metastatic EGFRm plus NSCLC who Progressed on First-Line EGFR TKIs-MedSci.cn

Real-World Data of Osimertinib in Patients with Metastatic EGFRm plus NSCLC who Progressed on First-Line EGFR TKIs

Ma, J; Tan, SH; Yin, D; Tran, A; Tan, D; Ang, M; Takano, A; Lim, KHT; Kanesvaran, R; Jain, A; Rajasekaran, T; Tan, E; Lim, DW; Ng, QS; Tan, W

JOURNAL OF THORACIC ONCOLOGY, 2021; 16 (3): S627

科室
- - 订阅+
  - 更多科室
工具
服务